Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $1.5 million.

  • Healthstream's Net Cash Flow fell 8716.32% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year decrease of 12922.25%. This contributed to the annual value of $19.2 million for FY2024, which is 43830.95% up from last year.
  • As of Q3 2025, Healthstream's Net Cash Flow stood at $1.5 million, which was down 8716.32% from -$25.2 million recorded in Q2 2025.
  • In the past 5 years, Healthstream's Net Cash Flow registered a high of $18.3 million during Q3 2023, and its lowest value of -$25.2 million during Q2 2025.
  • For the 5-year period, Healthstream's Net Cash Flow averaged around $901052.6, with its median value being $2.1 million (2024).
  • Its Net Cash Flow has fluctuated over the past 5 years, first surged by 32745.24% in 2024, then plummeted by 29893.94% in 2025.
  • Over the past 5 years, Healthstream's Net Cash Flow (Quarter) stood at -$8.5 million in 2021, then surged by 73.06% to -$2.3 million in 2022, then crashed by 66.97% to -$3.8 million in 2023, then surged by 153.51% to $2.1 million in 2024, then decreased by 29.33% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, -$25.2 million for Q2 2025, and $17.8 million during Q1 2025.